Skip to content

Clinical trials

Phase 3 Exanthema trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Exanthema Phase: Phase 3 Clear all

7 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20101
20131
20161
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed3
Withdrawn2
Recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Merz North America, Inc.2
Amgen1
Bristol-Myers Squibb1
Center for Research and Production of Vaccines and Biologicals, Vietnam1
Impaqtt Foundation1
Memorial Sloan Kettering Cancer Center1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Exanthema7
Pruritus3
Dermatitis2
Dermatitis, Atopic2
Eczema2
Fever2
Genetic Diseases, Inborn2
Hypersensitivity2
Hypersensitivity, Immediate2
Immune System Diseases2

Trials

Showing 1 to 7 of 7. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.